par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementAerie Pharmaceuticals Inc • November 6th, 2015 • Biological products, (no disgnostic substances) • New York
Company FiledNovember 6th, 2015 Industry JurisdictionAerie Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (“CF&Co”) (the “Agent”), as follows: